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OBSERVATIONS
Improved Peripheral
Perfusion During
Endothelin-A
Receptor Blockade in
Patients With Type 2
Diabetes and Critical
Limb Ischemia
E
ndothelin(ET)-1levelsareincreased
in patients with type 2 diabetes and
may contribute to vascular compli-
cations and insulin resistance. Recently,
we showed that ETA receptor blockade
improves nutritive skin capillary circula-
tion in patients with type 2 diabetes and
microangiopathy (1).
In this study, we investigated the ef-
fect of ETA receptor blockade on periph-
eral micro- and macrocirculation in six
patients (two female/four male; mean age
79  6 years) with type 2 diabetes and
critical limb ischemia (toe blood pressure
[TBP] 30 mmHg and presence of foot
ulcer), who were not eligible for vascular
reconstruction and/or angioplasty. The
study was approved by the ethics com-
mittee of the Karolinska Institute. Mea-
surements of systolic TBP (using laser
Doppler ﬂuxmetry as ﬂow detector) and
transcutaneous oxygen tension (TcPO2)
at the ﬁrst intermetatarsal space of the
foot were performed after 30 min of accli-
matization. A percutaneous catheter was
inserted into the femoral artery, and after
20 min the ETA receptor antagonist
BQ123 (Clinalfa, La ¨ufelﬁngen, Switzer-
land) was infused at a rate of 100 nmol/
min (5 ml/min) for 60 min. TBP and
TcPO2 were reevaluated after the 60-min
infusion of BQ123.
At baseline, the mean  SD TcPO2
was 10  9 mmHg (range 2–28) and TBP
was 13  7 mmHg (range 2–23). Follow-
ingthe60-mininfusionofBQ123,TcPO2
increasedto2015mmHg(range5–48;
P  0.05, Wilcoxon’s signed-rank test),
and TBP increased to 30  19 mmHg
(range 2–58; P  0.05). Systolic arm
bloodpressuredecreasedby10mmHgin
two patients, while it was unchanged in
four patients. Diastolic arm blood pres-
surewasunchangedinallpatients.Inone
patient,inwhomsystolicarmbloodpres-
sure decreased following the 60-min
BQ123 infusion, TBP increased from 11
to 38 mmHg, while TcPO2 decreased
from 13 to 10 mmHg. The other patient
with decreased arm blood pressure had
unchanged TBP and increased TcPO2.
Skintemperaturewasnotchangedduring
infusion of BQ123.
The results indicate that ETA receptor
blockade has a beneﬁcial effect on local
tissue perfusion in patients with type 2
diabetes and critical limb ischemia. The
effect may be a consequence of blocking
theprecapillaryconstrictoreffectsofET-1
mediated by ETA receptors, as well as im-
proved endothelium-dependent vasodi-
latation by enhancing the bioavailability
of nitric oxide. Targeting the ET-1 system
might be of importance in the treatment
of complications related to diabetic angi-
opathy and needs to be conﬁrmed in
larger placebo-controlled trials.
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